GlassScriptPhysician profile
Deepti C Bhandare
NPI 1568624427
$4,694.77
in general payments reported to CMS, 2019-2025
30 companies · $983 in 2025
The $983 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $425 · 2021: $441 · 2022: $501 · 2023: $866 · 2024: $1,000 · 2025: $983.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,848.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $814.11 | 2023-2025 | Amvuttra, Onpattro |
| Novartis Pharmaceuticals Corporation | $403.55 | 2019-2024 | |
| Pfizer INC. | $346.39 | 2019-2025 | |
| Amgen INC. | $296.03 | 2019-2024 | Repatha |
| Cvrx, INC. | $247.95 | 2022-2025 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $233.34 | 2022-2025 | Verquvo |
| Boston Scientific Corporation | $220.38 | 2019-2024 | Watchman Access System, Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $217.77 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $209.38 | 2019-2025 | Farxiga, Wainua |
| Philips North America LLC | $203.36 | 2020-2025 | (Ck7) Extended Holter, Holter, Extended Holter |
| E.R. Squibb & Sons, L.L.C. | $183.35 | 2019-2023 | Camzyos |
| Bridgebio Pharma, INC. | $166.43 | 2025 | Attruby |
| Abbott Laboratories | $152.89 | 2020-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Triclip |
| Janssen Pharmaceuticals, INC | $148.84 | 2020-2022 | |
| Lexicon Pharmaceuticals, INC. | $144.70 | 2024 | Inpefa |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $143.30 | 2023 | |
| Astellas Pharma US INC | $116.40 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.04 | 2019-2023 | Jardiance |
| Medtronic Vascular, INC. | $68.47 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $67.77 | 2019-2025 | Evkeeza |
| Biotronik INC. | $42.61 | 2023-2024 | Amvia Edge, Biomonitor, Rivacor 7 Dr-T |
| Kestra Medical Technology Services, INC. | $33.43 | 2023 | Assure Wcd |
| Irhythm Technologies, INC. | $30.83 | 2022-2023 | Zio Xt Patch |
| Vital Connect, INC | $28.64 | 2024 | Vitalpatch Rtm |
| Abiomed | $25.07 | 2022 | |
| Arbor Pharmaceuticals, INC. | $17.25 | 2019 | |
| Portola Pharmaceuticals, LLC | $15.71 | 2019 | |
| Alexion Pharmaceuticals, INC. | $13.97 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $12.81 | 2023 | Arcalyst |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepti Bhandare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.